
|Articles|June 15, 2003
Allergan, ACADIA to work on new drug chemistries
San Diego-ACADIA Pharmaceuticals will collaborate with Allergan Inc. to develop eye-care applications related to chemistries that ACADIA has identified for a wide range of G-protein coupled receptor and nuclear receptor targets.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























